Lecanemab, an Alzheimer’s medication, is heralded as a major development.
It has been called “historic” that the first drug to slow the brain damage caused by Alzheimer’s has been made. The scientific discovery puts a stop to decades of futility and demonstrates that new medication development for Alzheimer’s, the most prevalent type of dementia, is feasible. Lecanemab, however, has a negligible impact on people’s everyday […]